May 10 (Reuters) – U.S.-German medical device maker Siemens Healthineers (SHLG.DE) on Wednesday said it is giving up part of billion-dollar acquisition Corindus’ business as it reported a 30% drop in quarterly operating profit on lower contributions from COVID tests.
Adjusted earnings before interest and taxes (EBIT) fell to 681 million euros ($750 million) in the January-March period, less than the 702 million expected by analysts, according to a consensus provided by the company.
-Advertisement-
